US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

Biodesix Inc (BDSX)

19.16

1.81

(10.43%)

終了 6月24日 5:00AM

19.13

-0.03

(-0.16%)

取引時間後: 8:59AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Biodesix to Participate in Upcoming Investor Conferences

LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics...

Form 8-K - Current report

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Biodesix Announces First Quarter 2026 Results and Highlights

Delivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in Q1 2026;...

Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026

LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Biodesix Recognized as a Top Workplace for Third Consecutive Year

LOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Biodesix is proud to announce that it has earned the...

glenn1919

glenn1919 10月前

bdsx.................................................................a/h

INV4

Scotty9

Scotty9 1年前

Any news on the r/s voters passed it may 20th 1 to 2 or 20

Chrion Capital

Chrion Capital 1年前

+>>>BDSX - New Highs Printing for the day! Should continue into tomorrow. Insiders buying knows somethings coming.

Happy Trading

CC

subslover

subslover 1年前

Yes! I'm with you on that, good buddy!♥️

ollik78

ollik78 1年前

Looking for the $ coming months

glenn1919

glenn1919 1年前

BDSX......................................................................a/h

Scotty9

Scotty9 1年前

Thanks good to know

subslover

subslover 1年前

Heavy insider buying https://www.otcmarkets.com/filing/html?id=18485455&guid=Emc-kpRtlDqmB3h

glenn1919

glenn1919 1年前

BDSX.............................................................a/h

georgie18

georgie18 1年前

BDSX...96...🥳

georgie18

Member Level
Re: georgie18 post# 18

Wednesday, March 05, 2025 12:01:26 PM

Post#
20
of 20
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html

georgie18

georgie18 1年前

BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html

TrendTrade2016

TrendTrade2016 1年前

BDSX....SLOW GRIND TO A DOLLA

georgie18

georgie18 1年前

BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html

TrendTrade2016

TrendTrade2016 1年前

BDSX BOTTOM BUSTER

georgie18

georgie18 1年前

BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html

PonkenPlonken

PonkenPlonken 2年前

Mr Schuler is buying shares again

tw0122

Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.

tw0122

Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%

AJ Freely

AJ Freely 3年前

$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

1hot toddy

1hot toddy 4年前

WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$

Leg58

Lots if potential but will public offering dilute price?

Leg58

Lots if potential but will public offering dilute price?

subslover

subslover 4年前

Earnings look good.

subslover

subslover 4年前

Earnings look good.

MiamiGent

MiamiGent 4年前

BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX

carusso

carusso 4年前

crudeoil24

crudeoil24 4年前

LET'S GO BDSX !!!!!

crudeoil24

crudeoil24 4年前

Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY

crudeoil24

crudeoil24 4年前

Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.

Leg58

US based company is quietly trending up. IMHO.
GLTA

Lyxor Asset Management L...

Arogo Capital Acquisition

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。